… renal cell carcinoma treated in the period 2002 to 2012: update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations

M Lindskog, T Wahlgren, R Sandin, J Kowalski… - … Oncology: Seminars and …, 2017 - Elsevier
… benefits of nephrectomy and TT, respectively, for the elderly population and in M1 patients
… of fit patients. Importantly, however, our results indicate that synchronous metastases at RCC …

[HTML][HTML] Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden

K Hemminki, A Försti, A Hemminki, B Ljungberg… - PLoS …, 2021 - journals.plos.org
survival experience in Finland and Sweden over a period of … 1987–1991 and then declined
to the starting level; after 2002patients had distant metastases and the mean tumor size was …

Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …

B Ljungberg, P Sundqvist, P Lindblad… - … journal of urology, 2020 - Taylor & Francis
… to the Swedish National Population Register for overall survival … The present study in the
early TKI era, suggests that in a … -risk patients, since all had synchronous metastatic disease […

Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study

S Demasure, I Spriet, PR Debruyne, A Laenen… - Acta …, 2022 - Taylor & Francis
… (the cytokin era, which was in our study predominantly IFNa), … study including 4.217 Swedish
patients diagnosed with mRCC between 2002 and 2005, 2006 and 2008 or 2009 and 2012

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

J Redig, J Dalén, U Harmenberg… - … and Research, 2019 - Taylor & Francis
Overall survival and factors influencing overall survival in this … treated in the period 2002
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous metastatic

[HTML][HTML] Changes in treatment reality and survival of patients with advanced clear cell renal cell carcinomaanalyses from the german clinical RCC-registry

PJ Goebell, M Staehler, L Müller, A Nusch… - … Genitourinary Cancer, 2018 - Elsevier
Swedish RENCOMP (Renal Comparison) study that covered the time period 2002 to 2012.
… for this patient population until recently.23, 32 The Updated European Association of Urology …

[HTML][HTML] Treatment of advanced renal cell carcinoma: immunotherapies have demonstrated overall survival benefits while targeted therapies have not

O Hemminki, N Perlis, J Bjorklund, A Finelli… - European urology open …, 2020 - Elsevier
… listed as a treatment option for metastatic renal cell carcinoma in … During this time period,
indications for surgery have remained … However, an ad hoc subgroup analysis suggested no OS …

Metastatic papillary renal cell carcinoma in the era of targeted therapy–a retrospective study from three European academic centres

M Stenman, M Staehler, B Szabados… - Acta …, 2019 - Taylor & Francis
… (n = 86) referred to three academic centres in Sweden and … The aim of the study was to
evaluate overall survival (OS) of … Moreover, for patients with synchronous metastases

A population based study on Kidney Cancer in Norway (2008-2013). Aspects of biopsy use, surgical treatment and outcome

KM Hjelle - 2018 - bora.uib.no
… obtain updated numbers on kidney cancer (KC) treatment in … better cancer specific survival
(CSS) and overall survival (OS) [… The incidence of ipsilateral synchronous adrenal metastases

Comparative survival associated with use of targeted vs nontargeted therapy in medicare patients with metastatic renal cell carcinoma

P Li, J Jahnke, AR Pettit, YN Wong… - JAMA Network …, 2019 - jamanetwork.com
… , 36 our subgroup analysis of patients who had undergone … 44 ; in our study, unadjusted
median overall survival for the … our study period, and a recent analysis found greater survival